{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:55:38Z","timestamp":1787237738173,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre Poland","doi-asserted-by":"publisher","award":["2015\/17\/B\/ST4\/03717"],"award-info":[{"award-number":["2015\/17\/B\/ST4\/03717"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008648","name":"Leading National Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008648","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.saa.2019.03.011","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T21:17:26Z","timestamp":1551820646000},"page":"15-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Effect of phenothiazine compounds on the secondary structure and fibrillogenesis of poly-l-lysine"],"prefix":"10.1016","volume":"216","author":[{"given":"Katarzyna","family":"Cie\u015blik-Boczula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.saa.2019.03.011_bb0005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.drudis.2011.01.001","article-title":"Phenothiazine: the seven lives of pharmacology's first lead structure","volume":"16","author":"Ohlow","year":"2011","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.saa.2019.03.011_bb0010","unstructured":"World Health Organisation, (2009) WHO model lists of essential medicines. http:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/en\/"},{"key":"10.1016\/j.saa.2019.03.011_bb0015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejphar.2010.08.045","article-title":"Multiple non-psychiatric effects of phenothiazines: a review","volume":"648","author":"Sudeshna","year":"2010","journal-title":"Europ. J. Pharmacol."},{"key":"10.1016\/j.saa.2019.03.011_bb0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S1734-1140(12)70726-0","article-title":"Chemical structure of phenothiazines and their biological activity","volume":"64","author":"Jaszczyszyn","year":"2012","journal-title":"Pharmacol. Reports"},{"key":"10.1016\/j.saa.2019.03.011_bb0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0006-8993(03)02351-5","article-title":"Cytotoxicity of conventional and atypical antipsychotic drugs in relation to glucose metabolism","volume":"971","author":"Dwyer","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.saa.2019.03.011_bb0030","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0278-5846(97)00099-7","article-title":"Dose-response relationships for the antipsychotic effects and Parkinsonian side-effects of typical neuroleptic drugs: practical and theoretical implications","volume":"21","author":"Miller","year":"1997","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.saa.2019.03.011_bb0035","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1176\/ajp.152.5.765","article-title":"Fluphenazine plasma levels, dosage, efficacy, and side effects","volume":"152","author":"Levinson","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.saa.2019.03.011_bb0040","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0022-3476(66)80045-8","article-title":"Extrapyramidal dysfuction in an infant of a schizophrenic mother","volume":"69","author":"Hill","year":"1966","journal-title":"J. Pediatr."},{"key":"10.1016\/j.saa.2019.03.011_bb0045","first-page":"19","article-title":"Heriditary predisposition in drug-induced parkinsonism","volume":"6","author":"Myrianthopoulos","year":"1962","journal-title":"Arch. Nuerol."},{"key":"10.1016\/j.saa.2019.03.011_bb0050","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.2042-3306.1990.tb04227.x","article-title":"Fluphenazine induced Parkinson-like syndrome in a horse","volume":"22","author":"Brewer","year":"1990","journal-title":"Equine Vet. J."},{"key":"10.1016\/j.saa.2019.03.011_bb0055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0278-5846(98)00092-X","article-title":"Antipsychotic drugs affect glucose uptake and the expression of glucose transporters in PC12 cells","volume":"23","author":"Dwyer","year":"1999","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.saa.2019.03.011_bb0060","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1523\/JNEUROSCI.15-01-00117.1995","article-title":"Cytotoxic effects of sigma ligands: sigma receptor-mediated alterations in cellular morphology and viability","volume":"15","author":"Vilner","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.saa.2019.03.011_bb0065","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0922-4106(93)90029-9","article-title":"Sigma receptor-active neuroleptics are cytotoxic to C6 glioma cells in culture","volume":"244","author":"Vilner","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.saa.2019.03.011_bb0070","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1016\/0006-2952(85)90374-0","article-title":"Characteristics of the cytotoxic effects of the phenothiazine class of calmodulin antagonists","volume":"34","author":"Hait","year":"1985","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.saa.2019.03.011_bb0075","first-page":"2217","article-title":"Interaction of drugs with calmodulin","volume":"31","author":"Weiss","year":"1982","journal-title":"Biochemical, pharmacological and clinical implications, Biochem. Pharmacol."},{"key":"10.1016\/j.saa.2019.03.011_bb0080","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3181\/00379727-131-33931","article-title":"Cytotoxicity of phenothiazines on Chang liver cells as measured by enzyme leakage","volume":"131","author":"Dujovne","year":"1969","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.saa.2019.03.011_bb0085","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/npp.1993.50","article-title":"Tissue concentrations of clozapine and its metabolites in the rat","volume":"9","author":"Baldessarini","year":"1993","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.saa.2019.03.011_bb0090","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1176\/ajp.156.6.885","article-title":"Persistence of haloperidol in human brain tissue","volume":"156","author":"Kornhuber","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.saa.2019.03.011_bb0095","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1021\/acs.biochem.5b00399","article-title":"Fluphenazine\u00b7HCl and epigallocatechin Gallate modulate the rate of formation and structural properties of apolipoprotein C-II amyloid fibrils","volume":"54","author":"Zlatic","year":"2015","journal-title":"Biochem."},{"key":"10.1016\/j.saa.2019.03.011_bb0100","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.1021\/bi700411k","article-title":"Methylene blue inhibits amyloid A\u03b2 oligomerization by promoting fibrillization","volume":"46","author":"Necula","year":"2007","journal-title":"Biochem."},{"key":"10.1016\/j.saa.2019.03.011_bb0105","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.biochi.2017.03.006","article-title":"Alpha-helix to beta-sheet transition in long-chain poly-L-lysine: formation of alpha-helical fibrils by poly-L-lysine","volume":"137","author":"Cie\u015blik-Boczula","year":"2017","journal-title":"Biochim."},{"key":"10.1016\/j.saa.2019.03.011_bb0110","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bpc.2017.05.012","article-title":"The PPII-to-\u03b1-helix transition of poly-L-lysine in methanol\/water solvent mixtures accompanied by fibrillar self-aggregation: influence of fluphenazine molecules","volume":"227","author":"Cie\u015blik-Boczula","year":"2017","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.saa.2019.03.011_bb0115","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ijbiomac.2018.12.100","article-title":"Resveratrol modulates fibrillogenesis in a poly L lysine peptide","volume":"125","author":"Cie\u015blik-Boczula","year":"2019","journal-title":"Inter. J. Biol. Macromol."},{"key":"10.1016\/j.saa.2019.03.011_bb0120","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.1021\/ja00278a035","article-title":"Vibrational circular dichroism of polypeptides. 8. Poly(lysine) conformations as a function of pH in aqueous solution","volume":"108","author":"Yasui","year":"1986","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.saa.2019.03.011_bb0125","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/bip.360250915","article-title":"Vibrational circular dichroism spectra of three conformationally distinct states and an unordered state of poly-L-lysine in deuterated aqueous solution","volume":"25","author":"Paterlini","year":"1986","journal-title":"Biopolymers"},{"key":"10.1016\/j.saa.2019.03.011_bb0130","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/bip.10582","article-title":"Chain-length dependence of \u03b1-helix to \u03b2-sheet transition in polylysine: model of protein aggregation studied by temperature-tuned FTIR spectroscopy","volume":"73","author":"Dzwolak","year":"2004","journal-title":"Biopolymers"},{"key":"10.1016\/j.saa.2019.03.011_bb0135","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.saa.2017.08.045","article-title":"Interaction of anesthetic molecules with \u03b1-helix and polyproline II extended helix of long-chain poly-L-lysine","volume":"189","author":"Cie\u015blik-Boczula","year":"2018","journal-title":"Spectrochim. Acta Part A"},{"key":"10.1016\/j.saa.2019.03.011_bb0140","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.chemphyslip.2018.05.004","article-title":"Influence of resveratrol on interactions between negatively charged DPPC\/DPPG membranes and positively charged poly-L-lysine","volume":"214","author":"Cie\u015blik-Boczula","year":"2018","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.saa.2019.03.011_bb0145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.chemphys.2015.06.010","article-title":"FTIR-ATR study of the influence of the pyrimidine analog of fluphenazine on the chain-melting phase transition of sphingomyelin membranes","volume":"458","author":"Ku\u0107","year":"2015","journal-title":"Chem. Phys."},{"key":"10.1016\/j.saa.2019.03.011_bb0150","doi-asserted-by":"crossref","first-page":"40455","DOI":"10.1039\/C5RA04234H","article-title":"MCR-ALS as an effective tool for monitoring subsequent phase transitions in pure and doped DPPC liposome","volume":"5","author":"Cie\u015blik-Boczula","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.saa.2019.03.011_bb0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0009-3084(98)00022-X","article-title":"Study of the structure and phase behavior of dipalmitoylphosphatidylcholine by infrared spectroscopy: characterization of the pretransition and subtransition","volume":"94","author":"Bihan","year":"1998","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.saa.2019.03.011_bb0160","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ymeth.2004.03.012","article-title":"Techniques to study amyloid fibril formation in vitro","volume":"34","author":"Nilsson","year":"2004","journal-title":"Methods"},{"key":"10.1016\/j.saa.2019.03.011_bb0165","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/jsbi.2000.4221","article-title":"Review: history of the amyloid fibril","volume":"130","author":"Sipe","year":"2000","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.saa.2019.03.011_bb0170","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jsb.2004.08.002","article-title":"The binding of thioflavin-T to amyloid fibrils: lacalisation and implications","volume":"149","author":"Krebs","year":"2005","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.saa.2019.03.011_bb0175","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.brainresrev.2006.08.001","article-title":"Congo red and protein aggregation in neurodegenerative diseases","volume":"53","author":"Frid","year":"2007","journal-title":"Brain Resear. Rev."},{"key":"10.1016\/j.saa.2019.03.011_bb0180","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ijbiomac.2016.11.110","article-title":"Attenuation of amyloid fibrillation in presence of warfarin: a biophysical investigation","volume":"95","author":"Alam","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.saa.2019.03.011_bb0185","article-title":"Vitamin k3 inhibits protein aggregation: implication in the treatment of amyloid diseases","volume":"6","author":"Alam","year":"2006","journal-title":"Sci. Rep."},{"key":"10.1016\/j.saa.2019.03.011_bb0190","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00249-015-1019-8","article-title":"Effect of acidic and basic pH on Thioflavin T absorbance and fluorescence","volume":"44","author":"Hackl","year":"2015","journal-title":"Eur. Biophys. J."},{"key":"10.1016\/j.saa.2019.03.011_bb0195","unstructured":"V. Fodera, M. Groenning, V. Vetri, F. Librizzi, S. Spagnolo, C. Cornett, L. Olsen, M. van de Weert, M. Leone, Thiflavin T hydroxylation at basic pH and its effect on amyloid fibril detection, 112 (2008) 15174\u201315181."},{"key":"10.1016\/j.saa.2019.03.011_bb0200","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0022-2860(95)08589-N","article-title":"Studies of the binding mechanism of Congo red to poly(L-lysine) by absorption and circular dichroism spectroscopy","volume":"348","author":"Pigorsch","year":"1995","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.saa.2019.03.011_bb0205","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1177\/37.8.2666510","article-title":"Quantitative evaluation of Congo red binding to amyloid-like proteins with a beta-pleated sheet conformation","volume":"37","author":"Klunk","year":"1989","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.saa.2019.03.011_bb0210","doi-asserted-by":"crossref","unstructured":"D.F. Levinson, G.F. Simpson, H. Singh, K. Yadalam, A. Jain, M.J, Stephanos, P. Silver, Fluphenazine dose, clinical response, and extrapyramidal symptoms during acute treatment. Arch. Gen. Psychiatry 47 (1990) 761\u2013768.","DOI":"10.1001\/archpsyc.1990.01810200069010"},{"key":"10.1016\/j.saa.2019.03.011_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024844","article-title":"Styryl-based and tricyclic compounds as potential anti-prion agents","volume":"6","author":"Chung","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.saa.2019.03.011_bb0220","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/archpsyc.1968.01740040098013","article-title":"High-dose chlorpromazine therapy in chronic schizophrenia","volume":"18","author":"Prien","year":"1968","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.saa.2019.03.011_bb0225","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/BF00412672","article-title":"Chlorpromazine in chronic schizophrenia: behavioural dose-response relationships","volume":"18","author":"Clark","year":"1970","journal-title":"Psychopharmacologia"}],"container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142519302422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142519302422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T09:44:05Z","timestamp":1565171045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386142519302422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":45,"alternative-id":["S1386142519302422"],"URL":"https:\/\/doi.org\/10.1016\/j.saa.2019.03.011","relation":{},"ISSN":["1386-1425"],"issn-type":[{"value":"1386-1425","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of phenothiazine compounds on the secondary structure and fibrillogenesis of poly-l-lysine","name":"articletitle","label":"Article Title"},{"value":"Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.saa.2019.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}